31
Participants
Start Date
December 31, 2015
Primary Completion Date
January 31, 2017
Study Completion Date
NGM282
Placebo
NGM Clinical Study Site 1, Rochester
Lead Sponsor
NGM Biopharmaceuticals, Inc
INDUSTRY